If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

5 Jan 2026 07:19

RNS Number : 6254N
Compagnie de Saint-Gobain
05 January 2026
 

Saint-Gobain strengthens its presencein construction chemicals in Indonesia

 

On December 30, 2025 Saint-Gobain formed a JV with a subsidiary of Indocement Tunggal Prakarsa (a publicly traded Indonesian cement company 53% owned by Heidelberg Materials) to acquire Indocement's mortars business in Indonesia. The JV will be 60% held by Saint-Gobain with the remaining 40% held by Indocement Tunggall Prakarsa.

 

Indocement's mortars business is well-established in Indonesia with three production lines under the Tiga Roda brand and estimated sales of close to €20 million in 2025. Tiga Roda is a leading brand in white skim coat for finishing and is very complementary to Saint-Gobain's existing mortars business, Cipta Mortar Utama (CMU), both in product categories and geographic reach, strengthening customer intimacy across Indonesia.

 

Saint-Gobain has been present in Indonesia since 1995 and currently operates 14 production lines and employs around 1,300 people in the country. CMU is the leading player on the Indonesian market, thanks to 8 mortars production lines across the country, a comprehensive product portfolio and a network of close to 30,000 points of sale. CMU also benefits from Saint-Gobain's large presence across construction chemicals in Indonesia, thanks to its GCP (concrete admixtures and cement additives) and FOSROC (cement additives, resin flooring and technical mortars) brands.

 

The newly formed JV will leverage the strengths of Saint-Gobain's CMU, as well as those of Indocement, a leading cement manufacturer in Indonesia, to accelerate growth on the promising mortars market.

 

This acquisition is part of Saint-Gobain's strategy to further strengthen its business profile, in line with its "Lead & Grow" plan. It enhances Saint-Gobain's presence in the high-growth Indonesian market and is fully aligned with the Group's strategy to strengthen its worldwide presence in construction chemicals.

 

 

About Saint-Gobain

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group, celebrating its 360th anniversary in 2025, remains more committed than ever to its purpose "MAKING THE WORLD A BETTER HOME".

 

€46.6 billion in sales in 2024

More than 161,000 employees, locations in 80 countries

Committed to achieving net zero carbon emissions by 2050

 

For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain

 

 

Analyst/investor relations

Press relations

Vivien Dardel:

+33 1 88 54 29 77

Patricia Marie:

+33 1 88 54 26 83

Floriana Michalowska:

+33 1 88 54 19 09

Laure Bencheikh:

+33 1 88 54 26 38

Karim Safsaf:

+33 1 88 54 00 60

Yanice Biyogo:

 +33 1 88 54 27 96

James Weston: 

+33 1 88 54 01 24

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBAMRTMTBMMIF
Date   Source Headline
14th Apr 20207:12 amRNSCo-optation of a director
30th Mar 20207:07 amRNSIssue of Debt
23rd Mar 20207:34 amRNSCoronavirus pandemic update
10th Mar 20207:06 amRNSDisposal
28th Feb 20204:35 pmRNSPrice Monitoring Extension
27th Feb 20204:59 pmRNSFull-Year Results 2019
30th Jan 20207:02 amRNSAcquisition
24th Jan 20207:00 amRNSResolution of asbestos liabilities
21st Jan 20207:06 amRNSCDP Climate change A List
7th Jan 20205:07 pmRNSAcquisition
7th Jan 20207:07 amRNSAcquisition
6th Jan 20205:05 pmRNSDisposal
20th Dec 20197:08 amRNSDisposal
2nd Dec 20197:35 amRNSSaint-Gobain completes the divestment of DMTP
29th Nov 20195:15 pmRNSNew production line
29th Nov 20197:07 amRNSCancelation of shares
13th Nov 20197:00 amRNSAcquisition
4th Nov 20195:08 pmRNSDisposal
4th Nov 20197:04 amRNSDisposal
25th Oct 201912:18 pmRNS3rd Quarter Results
16th Oct 20197:07 amRNSAcquisition
7th Oct 20195:16 pmRNSDisposal
1st Oct 20195:07 pmRNSDisposal
30th Sep 20195:39 pmRNSDisposal
30th Sep 20197:21 amRNSDisposal
23rd Sep 20195:08 pmRNSCommitment
12th Sep 20196:15 pmRNSAmended Final Terms
26th Jul 20197:00 amRNSHalf-year Report
18th Jul 20195:16 pmRNSDisposal
1st Jul 20197:07 amRNSAccounting standards
19th Jun 20197:54 amRNSDisposal
14th Jun 20195:02 pmRNSCancellation of shares
7th Jun 20197:00 amRNSAGM Statement
28th May 20196:11 pmRNSAcquisition
20th May 20197:48 amRNSDisposal
14th May 20195:44 pmRNSFinal Terms
14th May 20195:16 pmRNSDisposal
2nd May 20195:32 pmRNSFinal Terms
25th Apr 20194:59 pmRNS1st Quarter Results
24th Apr 20197:08 amRNSAcquisition
8th Apr 20199:29 amRNSFinal Terms
25th Mar 20195:38 pmRNSFinal Terms
22nd Mar 20193:50 pmRNSFinal Terms
15th Mar 20197:00 amRNSFinal Terms
15th Mar 20197:00 amRNSFinal Terms
7th Mar 201910:24 amRNSStabilisation Notice
6th Mar 20195:34 pmRNSIssue of Debt
6th Mar 20199:01 amRNSStabilisation Notice
5th Mar 20195:42 pmRNSProspectus Supplement
21st Feb 20195:13 pmRNSAnnual Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.